Programa General - 6 agosto 2015
Programa Final SABCS Ciudad de México 2015 - 17 febrero 2015
Programa SABCS 2015 - 23 junio 2015
2014 Annual Meeting - 16 junio 2014
The San Antonio Breast Cancer Symposium - 25 septiembre 2013
Programa de Enfermeria - 5 septiembre 2013
Programa Cientifico - 5 septiembre 2013
Best of ASCO Ciudad de Mexico - 10 enero 2013
MPR LATAM provides consulting services for the pharmaceutical industry aiming to enter to the North American and Latin American market. We focus on Growth Strategy, Operations Management and Marketing Strategy. Whether entering to a new market, improving competitiveness or restructuring operations, we support our clients with many strategic decisions.
As regulations and market conditions continue to shift, companies need to become more effective in their approach to pharmaceutical sales. That's why we offer a range of alternatives designed to meet your specific needs. Partnering with MP&R provides an alternative to other commercialization strategies such as building new infrastructure or simply out-licensing.
Supported by a solid experience in clinical research, our medical division located in Mexico will bring a personalized focus to each project. We treat our customers as partners and make their projects our priority. Our professionals in Clinical Research apply their therapeutic, regulatory and operational experience to solve the problems that may appear.
Complying with regulatory and reporting requirements can be a major obstacle to enter a given market. At MPR LATAM we can help you find the most direct way to obtain regulatory approval so you can reach the market sooner. Let us find the most efficient route to commercialize your products and successfully comply with the local regulations.
Certainty, comparative effectiveness and cost evaluation are main issues in a product development especially after it's approval for commercialization. The immediate and appropriate identification of the security signals coming from any source in combination with a solid base for the subsequent clinical development are key elements in the life cycle of a product.